Airway, Therapeutics

Airway Therapeutics Israel Georgia

12.08.2025 - 14:01:14

Airway Therapeutics Receives European Medicines Agency Pediatric Committee Approval for Zelpultide Alfa's Study Plan in Bronchopulmonary Dysplasia for Very Preterm Infants

Multinational Phase 2b dose selection and Phase 3 expansion study for zelpultide alfa set to begin in late Q3/Q4 2025View original content:https://www.prnewswire.co.uk/news-releases/airway-therapeutics-receives-european-medicines-agency-pediatric-committee-approval-for-zelpultide-alfas-study-plan-in-bronchopulmonary-dysplasia-for-very-preterm-infants-302527017.html

@ prnewswire.co.uk